Zaowen Chen

发表

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

S. Agarwal, K. Rajapakshe, C. Coarfa, 2018, Oncotarget.

1 Expression of the G-CSF receptor, CD114, marks a novel, highly tumorigenic cell population in a neuroblastoma cell line

P. Gunaratne, C. Coarfa, Ashley L. Benham, 2013 .

p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy

Eugene S. Kim, Yankai Zhang, V. Sheehan, 2017, Clinical Cancer Research.

Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma.

Eugene S. Kim, F. Speleman, R. Versteeg, 2014, Cancer research.

A p53 Drug Response Signature Identifies Prognostic Genes in High-Risk Neuroblastoma

F. Speleman, P. Johansson, G. Tonini, 2013, PloS one.

G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Eugene S. Kim, P. Gunaratne, S. Agarwal, 2013, Cancer research.

Expression of the G-CSF receptor , CD 114 , marks a novel , highly tumorigenic cell population in a neuroblastoma cell line

Eugene S. Kim, P. Gunaratne, S. Agarwal, 2013 .

A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.

Aleksandar Milosavljevic, Cristian Coarfa, Eugene S. Kim, 2011, Cancer research.

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma

Eugene S. Kim, L. Vassilev, J. Shohet, 2011, Angiogenesis.

MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death

S. Berg, A. Slack, J. Shohet, 2006, Molecular Cancer Therapeutics.

MDM 2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death

S. Berg, A. Slack, J. Shohet, 2006 .

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

A. Pession, L. Hunt, R. Tonelli, 2005, Proceedings of the National Academy of Sciences of the United States of America.

G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Eugene S. Kim, S. Agarwal, A. Lakoma, 2015, Cancer research.

MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.

J. Hicks, A. Slack, J. Shohet, 2007, Cancer research.

Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.

Yunfu Lin, J. Hicks, J. Shohet, 2009, Neoplasia.

A Recombinant Antibody For Tracking Murine Gammaherpesvirus 68 Uracil DNA Glycosylase Expression

M. Zelazowska, Kevin M. McBride, Yunxiang Mu, 2023, bioRxiv.

Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma

Eugene S. Kim, P. Gunaratne, S. Agarwal, 2016, Oncotarget.

Divergent structures of Mammalian and gammaherpesvirus uracil DNA glycosylases confer distinct DNA binding and substrate activity.

M. Zelazowska, Kevin M. McBride, Yunxiang Mu, 2023, DNA repair.

The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma

S. Agarwal, J. Jackson, A. Lakoma, 2015, Cell Death Discovery.

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma Danielle M. PattersonDongbing GaoDenae N. TrahanBrett A. Johnson • Andrew LudwigEveline BarbieriZaowen ChenJose Diaz-Miron • Lyubomir VassilevJason M. ShohetEugene S. Kim

L. Vassilev, J. Shohet, Zaowen Chen, 2011 .

Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis

D. Roop, M. Koster, J. Nuchtern, 2006, Oncogene.

G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Eugene S. Kim, S. Agarwal, A. Lakoma, 2015, Cancer Research.